Pulse Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	95.21	118.04	44.37	61.14	28.61	12.46
Short-Term Investments	-	-	-	-	-	8.01
Cash & Short-Term Investments	95.21	118.04	44.37	61.14	28.61	20.48
Cash Growth	20.47%	166.06%	-27.44%	113.67%	39.75%	-19.38%
Receivables	0.02	-	-	-	0.06	-
Inventory	0.06	-	-	-	5.82	-
Prepaid Expenses	1.87	1.41	0.96	1.01	2.13	1.86
Total Current Assets	97.16	119.45	45.33	62.15	36.63	22.34
Property, Plant & Equipment	7.37	8.32	8.78	10.02	11.25	11.92
Goodwill	2.79	2.79	2.79	2.79	2.79	2.79
Other Intangible Assets	0.74	1.22	1.89	2.55	3.22	3.88
Other Long-Term Assets	0.71	0.68	0.37	0.37	0.37	0.37
Total Assets	108.77	132.46	59.15	77.88	54.25	41.29
Accounts Payable	2.98	1.67	1.84	1.57	2.9	1.72
Accrued Expenses	5.2	5.83	3.81	2.55	3.78	3.76
Short-Term Debt	-	-	-	-	0.44	-
Current Portion of Long-Term Debt	-	-	-	0.92	-	-
Current Portion of Leases	1.52	1.36	1.06	0.9	0.77	0.54
Current Unearned Revenue	-	-	-	-	0.02	-
Other Current Liabilities	-	1.2	-	0.05	0.61	1.56
Total Current Liabilities	9.7	10.06	6.71	5.98	8.52	7.59
Long-Term Debt	-	-	-	65	-	-
Long-Term Leases	6.37	7.54	8.09	9.14	10.04	10.81
Total Liabilities	16.07	17.6	14.79	80.13	18.56	18.4
Common Stock	0.07	0.07	0.06	0.04	0.03	0.03
Additional Paid-In Capital	538.47	505.3	381.22	292.42	271.86	195.41
Retained Earnings	-445.85	-390.5	-336.92	-294.71	-236.2	-172.54
Comprehensive Income & Other	-	-	-	-	-	-0
Shareholders' Equity	92.69	114.86	44.36	-2.25	35.69	22.89
Total Liabilities & Equity	108.77	132.46	59.15	77.88	54.25	41.29
Total Debt	7.89	8.9	9.14	75.96	11.25	11.36
Net Cash (Debt)	87.32	109.14	35.22	-14.82	17.36	9.12
Net Cash Growth	23.57%	209.87%	-	-	90.42%	-51.18%
Net Cash Per Share	1.32	1.87	0.71	-0.44	0.62	0.39
Filing Date Shares Outstanding	67.77	67.27	55.23	37.59	29.8	26.09
Total Common Shares Outstanding	67.74	65.93	55.14	37.24	29.72	25.55
Working Capital	87.46	109.39	38.62	56.17	28.11	14.75
Book Value Per Share	1.37	1.74	0.80	-0.06	1.20	0.90
Tangible Book Value	89.16	110.85	39.68	-7.59	29.68	16.22
Tangible Book Value Per Share	1.32	1.68	0.72	-0.20	1.00	0.63
Machinery	2.49	2.31	2.21	2.08	1.95	1.4
Construction In Progress	0.05	0.03	-	0.02	0.19	0.07
Leasehold Improvements	2.52	2.52	2.52	2.52	2.52	2.81

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q